The p.N680S sequence variation of the follicle-stimulating hormone (FSH) receptor gene was previously shown to influence the ovarian response to FSH in normo-ovulatory women undergoing controlled ovarian hyperstimulation. In this prospective, randomized, controlled study, we tested whether the same daily dose of FSH results in lower levels of oestradiol in women homozygous for the p.N680S sequence variation, and whether the difference can be overcome by higher FSH doses. Women undergoing controlled ovarian hyperstimulation for in vitro fertilization or intracytoplasmic sperm injection and homozygous for the wild-type or for the p.N680S FSH receptor were randomly assigned to group I (Ser/Ser, n=24), receiving an FSH dose of 150 U/day, or group II (Ser/Ser, n=25), receiving an FSH dose of 225 U/day. In group III (Asn/Asn, n=44), the FSH dose was 150 U/day. Age and basal FSH levels were not different between groups. At ovulation induction, total FSH doses were comparable in group I (1631+/-96 U) and group III (1640+/-57 U) but significantly higher in group II (2421+/-112 U) (P<0.001). Peak oestradiol levels on the day of human chorionic gonadotrophin (hCG) administration were significantly lower in group I (5680+/-675 pmol/l) compared to group III (8679+/-804 pmol/l) (P=0.028). Increasing the FSH dose from 150 to 225 U/day overcame the lower oestradiol response in women with Ser/Ser (group II, 7804+/-983 pmol/l). In women undergoing controlled ovarian hyperstimulation, the p.N680S sequence variation results in lower oestradiol levels following FSH stimulation. This lower FSH receptor sensitivity can be overcome by higher FSH doses.

Significance of a common single nucleotide polymorphism in exon of the follicle-stimulating hormone receptor gene for ovarian response to FSH: a pharmacogenetic approach to control ovarian hyperstimulation / Behre, Hm; Greb, Rr; Mempel, A; Sonntag, B; Kiesel, L; Kaltwasser, P; Seliger, E; Röpke, F; Gromoll, J; Nieschlag, E; Simoni, Manuela. - In: PHARMACOGENETICS AND GENOMICS. - ISSN 1744-6872. - ELETTRONICO. - 15:(2005), pp. 451-456.

Significance of a common single nucleotide polymorphism in exon of the follicle-stimulating hormone receptor gene for ovarian response to FSH: a pharmacogenetic approach to control ovarian hyperstimulation.

SIMONI, Manuela
2005

Abstract

The p.N680S sequence variation of the follicle-stimulating hormone (FSH) receptor gene was previously shown to influence the ovarian response to FSH in normo-ovulatory women undergoing controlled ovarian hyperstimulation. In this prospective, randomized, controlled study, we tested whether the same daily dose of FSH results in lower levels of oestradiol in women homozygous for the p.N680S sequence variation, and whether the difference can be overcome by higher FSH doses. Women undergoing controlled ovarian hyperstimulation for in vitro fertilization or intracytoplasmic sperm injection and homozygous for the wild-type or for the p.N680S FSH receptor were randomly assigned to group I (Ser/Ser, n=24), receiving an FSH dose of 150 U/day, or group II (Ser/Ser, n=25), receiving an FSH dose of 225 U/day. In group III (Asn/Asn, n=44), the FSH dose was 150 U/day. Age and basal FSH levels were not different between groups. At ovulation induction, total FSH doses were comparable in group I (1631+/-96 U) and group III (1640+/-57 U) but significantly higher in group II (2421+/-112 U) (P<0.001). Peak oestradiol levels on the day of human chorionic gonadotrophin (hCG) administration were significantly lower in group I (5680+/-675 pmol/l) compared to group III (8679+/-804 pmol/l) (P=0.028). Increasing the FSH dose from 150 to 225 U/day overcame the lower oestradiol response in women with Ser/Ser (group II, 7804+/-983 pmol/l). In women undergoing controlled ovarian hyperstimulation, the p.N680S sequence variation results in lower oestradiol levels following FSH stimulation. This lower FSH receptor sensitivity can be overcome by higher FSH doses.
15
451
456
Significance of a common single nucleotide polymorphism in exon of the follicle-stimulating hormone receptor gene for ovarian response to FSH: a pharmacogenetic approach to control ovarian hyperstimulation / Behre, Hm; Greb, Rr; Mempel, A; Sonntag, B; Kiesel, L; Kaltwasser, P; Seliger, E; Röpke, F; Gromoll, J; Nieschlag, E; Simoni, Manuela. - In: PHARMACOGENETICS AND GENOMICS. - ISSN 1744-6872. - ELETTRONICO. - 15:(2005), pp. 451-456.
Behre, Hm; Greb, Rr; Mempel, A; Sonntag, B; Kiesel, L; Kaltwasser, P; Seliger, E; Röpke, F; Gromoll, J; Nieschlag, E; Simoni, Manuela
File in questo prodotto:
File Dimensione Formato  
90.pdf

non disponibili

Tipologia: Post-print dell'autore (bozza post referaggio)
Dimensione 85.6 kB
Formato Adobe PDF
85.6 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/607583
Citazioni
  • ???jsp.display-item.citation.pmc??? 41
  • Scopus 163
  • ???jsp.display-item.citation.isi??? 145
social impact